MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.
Conclusion: miR-182 can inhibit the proliferation of LSCC cells by directly inhibiting the expressions of CRR9, thereby suppressing the occurrences and developments of LSCC.
PMID: 31519771 [PubMed - as supplied by publisher]
Source: Bioscience Reports - Category: Biomedical Science Authors: Lv Y, Ye D, Qiu S, Zhang J, Shen Z, Shen Y, Deng H Tags: Biosci Rep Source Type: research
More News: Biomedical Science | Cancer & Oncology | Carcinoma | Genetics | Laryngeal Cancer | Skin Cancer | Squamous Cell Carcinoma